Congressional Testimony 2002

-

December

12/11/2002 Concerns Regarding Accutane (isotretinoin)
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
12/10/2002 Ongoing Response to Vaccines and Autism Issues
Karen Midthun, M.D., before the House Committee on Government Reform

-

11/14/2002 Regulation of Dental Amalgams
David W. Feigal, M.D., M.P.H., before the House Committee on Government Reform

-

10/09/2002 Implementation of the Drug Price Competition and Patent Term Restoration Act of 1984
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
10/08/2002 Regulatory Framework of DSHEA of 1994
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring and the District of Columbia
10/03/2002 Response to the Emerging Threat of West Nile Virus (WNV)
Jesse L. Goodman, M.D., M.P.H., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources

-

09/24/2002 Response to the Emerging Threat of Transmission of West Nile Virus (WNV) Through Blood and Tissue
Jesse Goodman, M.D., M.P.H., before the Senate Committee on Governmental Affairs, and the Committee on Health, Education, Labor, and Pensions, Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia

-

08/05/2002 Ensuring Safe FDA-regulated Products at the Port of Tampa
Gary J. Dykstra, before the House Committee on Government Reform, Subcommittee on National Security, Veterans Affairs and International Relations

-

07/31/2002 Dietary Supplements and Their Use for Weight-loss Purposes
Joseph A. Levitt, Esq., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia
07/25/2002 The Importation of Drugs into the United States
William K. Hubbard, before the House Committee on Energy and Commerce, Subcommittee on Health
07/09/2002 Importation of Drugs
William K. Hubbard, before the Senate Special Committee on Aging

-

06/12/2002 Current Shortage of Childhood Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on Governmental Affairs

-

04/30/2002 Safety of Federal School Lunches
Lester M. Crawford, D.V.M., Ph.D., before the Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring and the District of Columbia

-

03/21/2002 Fiscal Year 2003 Budget Request
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies
03/06/2002 Success in Implementing the Prescription Drug User Fee Act (PDUFA)
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health

-

02/28/2002 Mammography Quality Standards Act (MQSA) of 1992
Written Statement for the Record, before the Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Public Health, and the Committee on Appropriations, Subcommittee on Labor, Health and Human Services, and Education
02/12/2002 Oxycontin: Balancing Risks and Benefits
John K. Jenkins, M.D., before the Senate Committee on Health, Education, Labor, and Pensions

-